Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jie Wang, (b)"'
Autor:
Mengjie Xiao, Yufeng Tang, Jie Wang, (a), Guangping Lu, Jianlou Niu, Jie Wang, (b), Jiahao Li, Qingbo Liu, Zhaoyun Wang, Zhifeng Huang, Yuanfang Guo, Ting Gao, Xiaohui Zhang, Shouwei Yue, Junlian Gu
Publikováno v:
Redox Biology, Vol 49, Iss , Pp 102219- (2022)
A cumulative and progressively developing cardiomyopathy induced by adriamycin (ADR)-based chemotherapy is a major obstacle for its clinical application. However, there is a lack of safe and effective method to protect against ADR-induced cardiotoxic
Externí odkaz:
https://doaj.org/article/b645fa1d6819406081db440ee2eea024
Autor:
Jie Wang(a), Yufeng Tang, Jingjing Zhang, Jie Wang(b), Mengjie Xiao, Guangping Lu, Jiahao Li, Qingbo Liu, Yuanfang Guo, Junlian Gu
Publikováno v:
Redox Biology, Vol 52, Iss , Pp 102310- (2022)
Although it is known that the expression and activity of sirtuin 1 (SIRT1) significantly decrease in doxorubicin (DOX)-induced cardiomyopathy, the role of interaction between SIRT1 and sestrin 2 (SESN2) is largely unknown. In this study, we investiga
Externí odkaz:
https://doaj.org/article/fb966a552dde4b30a0ee7ad81a260e23
Autor:
Jie Wang(a), Jingjing Zhang, Mengjie Xiao, Shudong Wang, Jie Wang(b), Yuanfang Guo, Yufeng Tang, Junlian Gu
Publikováno v:
Cellular and Molecular Life Sciences. 78:3105-3125
Doxorubicin (DOX) is an anthracycline chemotherapy drug used in the treatment of various types of cancer. However, short-term and long-term cardiotoxicity limits the clinical application of DOX. Currently, dexrazoxane is the only approved treatment b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3111cd8a8bb38a5ea742b838f6c4766
https://doi.org/10.1007/s00018-020-03729-y
https://doi.org/10.1007/s00018-020-03729-y
Autor:
Jingjing Zhang, Mengjie Xiao, Jie Wang A, Yuanfang Guo, Yufeng Tang, Junlian Gu, Shudong Wang, Jie Wang B
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 11 (2021)
Frontiers in Endocrinology, Vol 11 (2021)
Diabetes mellitus (DM) has been one of the largest health concerns of the 21st century due to the serious complications associated with the disease. Therefore, it is essential to investigate the pathogenesis of DM and develop novel strategies to redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9bd4c24132248ac4ad8f3b35715a15
http://europepmc.org/articles/PMC7848207
http://europepmc.org/articles/PMC7848207
Autor:
Jie Wang(b), Shudong Wang, Mengjie Xiao, Jingjing Zhang, Jie Wang(a), Yuanfang Guo, Yufeng Tang, Junlian Gu
Publikováno v:
Pharmacological Research. 164:105331
Sestrin2 (Sesn2) is a powerful anti-oxidant that can prevent acute and chronic diseases. The role of Sesn2 has been thoroughly reviewed in liver, nervous system, and immune system diseases. However, there is a limited number of reviews that have summ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f64a266199bd744f5a2e2788a6034f
https://doi.org/10.1016/j.phrs.2020.105331
https://doi.org/10.1016/j.phrs.2020.105331
Autor:
Jie Wang(a), Shudong Wang, Jie Wang(b), Mengjie Xiao, Yuanfang Guo, Yufeng Tang, Jingjing Zhang, Junlian Gu
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
Diabetes mellitus (DM) has been one of the largest health concerns of the 21st century due to the serious complications associated with the disease. Therefore, it is essential to investigate the pathogenesis of DM and develop novel strategies to redu
Externí odkaz:
https://doaj.org/article/4b27510a335346f2b71d62106d7100a9